Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Tsavlis (Thessaloniki, Greece), D. Anestakis (Thessaloniki, Greece), P. Konstantinidou (Thessaloniki, Greece), K. Symeonidou (Thessaloniki, Greece), D. Koutsonikolas (Thessaloniki, Greece), A. Tzoumaka (Thessaloniki, Greece), E. Spandou (Thessaloniki, Greece). Erythropoietin (EPO) attenuates the immunohistochemical expression of autophagy antibodies in bleomycin (BLM), induced pulmonary fibrosis (PF) in rats. 2425

Member's Comments

No comment yet.

Related content which might interest you: Erythropoietin (EPO) attenuates the immunohistochemical expression of tumor growth factor-ß (TGF-ß) in bleomycin (BLM)-induced pulmonary fibrosis (PF) in rats Source: International Congress 2018 – Pulmonary fibrosis: from models to patients Year: 2018 Erythropoietin (EPO) attenuates the expression of its receptor (EPO-R) in bleomycin (BLM)-induced pulmonary fibrosis (PF) in rats Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation Year: 2012 Erythropoietin (EPO) inhibits the bleomycin (BLM)-induced pulmonary fibrosis in rats Source: Annual Congress 2010 - Emerging mechanisms in lung injury Year: 2010 The effect of erythropoietin (EPO) on cyclooxygenase-2 (COX-2) and cytochrome-c (CYT-c) in the bleomycin (BLM)-induced pulmonary fibrosis (PF) in rats Source: Annual Congress 2011 - The ageing pulmonary interstitium Year: 2011 Erythropoietin (EPO) inhibits the immunohistochemical expression of lysyl oxidase (LOX) in bleomycin (BLM)-induced pulmonary fibrosis (PF) in rats Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 The attenuating effect of erythropoietin (EPO) on the expression of myeloperoxidase (MPO) in bleomycin-induced pulmonary fibrosis in rats Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury Year: 2013 Post-treatment with the heat shock protein 90 (hsp90) inhibitor, AUY-922, reduces lung hsp90 tyrosine (Y) phosphorylation and pulmonary inflammation in LPS-induced acute lung injury (ALI) in mice Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury Year: 2013 Hepatocyte growth factor (HGF) expression in bronchoveolar lower (BAL) does not confirm its anti-fibrotic activity in interstitial lung diseases (ILD) Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012 Bleomycin induced lung fibrosis in mice is attenuated by a new somatostatin analog Source: Annual Congress 2006 - Matrix remodelling at the interface of lung fibrosis and emphysema Year: 2006 Aminoguanidine attenuates bleomycin-induced pulmonary fibrosis in rats through inhibition of heat shock protein 47 and TGF-β1 expression Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies Year: 2008 Oral N-acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats Source: Eur Respir J 2003 Dec 01;22(6):900-905 Year: 2003 Disruption of Nrf2 enhances susceptibility to pulmonary fibrosis induced by bleomycin in mice Source: Annual Congress 2011 - The ageing pulmonary interstitium Year: 2011 Tankyrase(TNKS) inhibiting autophagy promotes the TGF-ß induced EMT process in vitro and Bleomycin(BLM) induced pulmonary fibrosis in rats Source: International Congress 2019 – Translational aspects of idiopathic pulmonary fibrosis Year: 2019 Pirfenidone attenuates expression of HSP47 in murine bleomycin-induced pulmonary fibrosis Source: Eur Respir J 2004; 24: 57-65 Year: 2004 Fas Ligand (FasL) expressed on alveolar lymphocytes (AL) plays role in progression of interstitial lung diseases (ILD) but not in local induction of immune cells apoptosis Source: Eur Respir J 2005; 26: Suppl. 49, 542s Year: 2005 TGF-beta-dependent inhibitor of DNA protein (Id) expression in lung fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 521s Year: 2006 Attenuation by oral N-acetylcysteine of bleomycin-induced lung injury in rats Source: Eur Respir J 2001; 17: 1228-1235 Year: 2001 Enhanced expression of interleukin 8 (CXCL8) in cystic fibrosis (CF) airway epithelial (AE) cells Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science Year: 2013 Romidepsin (FK228) target focal adhesion kinase (FAK) expression in lung fibrosis Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 The rapamycin analogue SDZ RAD attenuates bleomycin-induced pulmonary fibrosis in rats Source: Eur Respir J 2002; 19: 1124-1127 Year: 2002